Medical Center Stanford University banned their doctors accept gifts (including children) from representatives of pharmaceutical companies, under a new policy that seeks to limit industry influence on patient care and medical education.
The new rules, to be announced today, are part of a growing trend among academic medical centers. Yale and the University of Pennsylvania, for example, have announced similar policies.
Showing posts with label Drugs. Show all posts
Showing posts with label Drugs. Show all posts
Wednesday, December 26, 2012
Saturday, December 1, 2012
Information on Neupogen
Composition: Vial: Each 1 ml vial contains: Filgrastim 30 million IU equal to 300 mcg. Preloaded Syringe: Each pre-filled syringe of 1 ml contains 30 million IU Filgrastim equal to 300 mcg ...
Therapeutic Action: Human factor granulocyte colony stimulating recombinant (Filgrastim or rHuG-CSF).
Directions: So the main uses of Neupogen (G-CSF) at present are: treatment of febrile neutropenia induced by cancer chemotherapy standard. Neupogen (G-CSF) reduces the intensity and duration of neutropenia straight to anticancer chemotherapy and reduces the incidence, duration and severity of infections that accompany the neutropenia in these patients. Treatment of neutropenia from chemotherapy with autologous bone marrow transplantation. Treatment of chronic congenital neutropenia, idiopathic, cyclic neutropenia in children and caused by radiation therapy, steroids, antiinflammatory, antithyroid drugs, AZT, and drugs in general. In patients with infection and leucopenia Neupogen can help bone marrow recovery.
Therapeutic Action: Human factor granulocyte colony stimulating recombinant (Filgrastim or rHuG-CSF).
Directions: So the main uses of Neupogen (G-CSF) at present are: treatment of febrile neutropenia induced by cancer chemotherapy standard. Neupogen (G-CSF) reduces the intensity and duration of neutropenia straight to anticancer chemotherapy and reduces the incidence, duration and severity of infections that accompany the neutropenia in these patients. Treatment of neutropenia from chemotherapy with autologous bone marrow transplantation. Treatment of chronic congenital neutropenia, idiopathic, cyclic neutropenia in children and caused by radiation therapy, steroids, antiinflammatory, antithyroid drugs, AZT, and drugs in general. In patients with infection and leucopenia Neupogen can help bone marrow recovery.
FAQ Bru therapy
What is therapy?
The therapy is cause neutrophilia (neutrophil count elevation) in the vicinity of the patient's tumors ...
Neutrophils are immune cells that, unlike other body cells, supporting the acidic environment generated by the tumor environment. According to the work of A. Bru, these cells are capable of exerting pressure on the tumor. Tumor cells pressurized first enter a quiescent state, which do not divide, and then die by necrosis. To cause neutrophilia is injected the patient Neupogen ®.
The therapy is cause neutrophilia (neutrophil count elevation) in the vicinity of the patient's tumors ...
Neutrophils are immune cells that, unlike other body cells, supporting the acidic environment generated by the tumor environment. According to the work of A. Bru, these cells are capable of exerting pressure on the tumor. Tumor cells pressurized first enter a quiescent state, which do not divide, and then die by necrosis. To cause neutrophilia is injected the patient Neupogen ®.
Subscribe to:
Posts (Atom)